Bain Capital Life Sciences Investors, LLC Nautilus Biotechnology, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $557 Million
- Q3 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,000,000 shares of NAUT stock, worth $3.52 Million. This represents 1.02% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,000,000
-0.0%
Holding current value
$3.52 Million
Previous $4.68 Million
21.79%
% of portfolio
1.02%
Previous 0.96%
Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
86Shares Held
64.3MCall Options Held
1.9KPut Options Held
100-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$28.7 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$22.2 Million0.94% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$12.6 Million0.51% of portfolio
-
Madrona Venture Group, LLC6.02MShares$10.6 Million23.0% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.74 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $219M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...